Ascendis Pharma (NASDAQ: ASND) received FDA orphan status for its treatment of Achondroplasia. Generic Name: C-type natriuretic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE